Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Potassium Cardioplegia in Solitary Valvular Disease
NCT04306913Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of esmolol in valvular heart disease (VHD) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Coronary sinus lactate level immediately before declamping the aorta. Status: unknown.
02
Drugs
esmolol
03
Conditions
valvular heart disease (VHD)
Beyond the preview
Go deeper on NCT04306913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04306913.